Cellular Pathogenesis of Hepatic Encephalopathy: An Update

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2023 Feb 25

PMID 36830765

Authors

Kaihui Lu

Affiliations

Soon will be listed here.

Abstract

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome derived from metabolic disorders due to various liver failures. Clinically, HE is characterized by hyperammonemia, EEG abnormalities, and different degrees of disturbance in sensory, motor, and cognitive functions. The molecular mechanism of HE has not been fully elucidated, although it is generally accepted that HE occurs under the influence of miscellaneous factors, especially the synergistic effect of toxin accumulation and severe metabolism disturbance. This review summarizes the recently discovered cellular mechanisms involved in the pathogenesis of HE. Among the existing hypotheses, ammonia poisoning and the subsequent oxidative/nitrosative stress remain the mainstream theories, and reducing blood ammonia is thus the main strategy for the treatment of HE. Other pathological mechanisms mainly include manganese toxicity, autophagy inhibition, mitochondrial damage, inflammation, and senescence, proposing new avenues for future therapeutic interventions.

Citing Articles

Hepatic encephalopathy: risk identification and prophylaxis approaches.

Torre A, Cordova-Gallardo J, Martinez-Sanchez F Metab Brain Dis. 2025; 40(3):138.

PMID: 40053146 DOI: 10.1007/s11011-025-01531-y.

Brain Functional Connectivity Significantly Improves After Surgical Eradication of Porto-Systemic Shunting in Pediatric Patients.

Sparacia G, Parla G, Miraglia R, de Ville de Goyet J Life (Basel). 2025; 15(2).

PMID: 40003699 PMC: 11856844. DOI: 10.3390/life15020290.

Edaravone reduces brain injury in hepatic encephalopathy by upregulation of Nrf2/HO-1 and inhibition of NF-κB, iNOS/NO and inflammatory cytokines.

Amirshahrokhi K, Imani M Mol Biol Rep. 2025; 52(1):222.

PMID: 39937373 DOI: 10.1007/s11033-025-10343-3.

Stem cell transplantation therapy for advanced liver damage-associated neurodegenerative disorders.

Sharma A, Sharma A, Dheer D, Sharma R, Puri V, Bibi S Int J Surg. 2024; 110(11):6873-6882.

PMID: 39699862 PMC: 11573053. DOI: 10.1097/JS9.0000000000002001.

The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential.

Johnson C, Stevens C, Bennett M, Litch A, Rodrigue E, Quintanilla M Nutrients. 2024; 16(23).

PMID: 39683402 PMC: 11643663. DOI: 10.3390/nu16234007.

References

Haussinger D, Laubenberger J, Vom Dahl S, Ernst T, Bayer S, Langer M . Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology. 1994; 107(5):1475-80. DOI: 10.1016/0016-5085(94)90552-5. View

Zemtsova I, Gorg B, Keitel V, Bidmon H, Schror K, Haussinger D . Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 2011; 54(1):204-15. DOI: 10.1002/hep.24326. View

Bai G, Rama Rao K, Murthy C, Panickar K, Jayakumar A, Norenberg M . Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res. 2001; 66(5):981-91. DOI: 10.1002/jnr.10056. View

Keitel V, Gorg B, Bidmon H, Zemtsova I, Spomer L, Zilles K . The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia. 2010; 58(15):1794-805. DOI: 10.1002/glia.21049. View

Frieg B, Gorg B, Gohlke H, Haussinger D . Glutamine synthetase as a central element in hepatic glutamine and ammonia metabolism: novel aspects. Biol Chem. 2021; 402(9):1063-1072. DOI: 10.1515/hsz-2021-0166. View

Hazell A . Astrocytes and manganese neurotoxicity. Neurochem Int. 2002; 41(4):271-7. DOI: 10.1016/s0197-0186(02)00013-x. View

Hamdani E, Popek M, Frontczak-Baniewicz M, Utheim T, Albrecht J, Zielinska M . Perturbation of astroglial Slc38 glutamine transporters by NH contributes to neurophysiologic manifestations in acute liver failure. FASEB J. 2021; 35(7):e21588. DOI: 10.1096/fj.202001712RR. View

Zhang Y, Tan S, Du J, Chen Y, Jia J, Feng J . Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy. Int Immunopharmacol. 2021; 96:107795. DOI: 10.1016/j.intimp.2021.107795. View

Malaguarnera M, Balzano T, Castro M, Llansola M, Felipo V . The Dual Role of the GABA Receptor in Peripheral Inflammation and Neuroinflammation: A Study in Hyperammonemic Rats. Int J Mol Sci. 2021; 22(13). PMC: 8268725. DOI: 10.3390/ijms22136772. View

10.

Elsherbini D, Ghoneim F, El-Mancy E, Ebrahim H, El-Sherbiny M, El-Shafey M . Astrocytes profiling in acute hepatic encephalopathy: Possible enrolling of glial fibrillary acidic protein, tumor necrosis factor-alpha, inwardly rectifying potassium channel (Kir 4.1) and aquaporin-4 in rat cerebral cortex. Front Cell Neurosci. 2022; 16:896172. PMC: 9428715. DOI: 10.3389/fncel.2022.896172. View

11.

Tarazona S, Carmona H, Conesa A, Llansola M, Felipo V . A multi-omic study for uncovering molecular mechanisms associated with hyperammonemia-induced cerebellar function impairment in rats. Cell Biol Toxicol. 2021; 37(1):129-149. DOI: 10.1007/s10565-020-09572-y. View

12.

Gorg B, Qvartskhava N, Keitel V, Bidmon H, Selbach O, Schliess F . Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo. Hepatology. 2008; 48(2):567-79. DOI: 10.1002/hep.22345. View

13.

Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger D . Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology. 2005; 41(5):1065-73. DOI: 10.1002/hep.20662. View

14.

Ryu A, Rahimi R, Leise M . The Current Hepatic Encephalopathy Pipeline. J Clin Exp Hepatol. 2020; 10(4):377-385. PMC: 7335727. DOI: 10.1016/j.jceh.2020.01.001. View

15.

Arenas Y, Balzano T, Ivaylova G, Llansola M, Felipo V . The S1PR2-CCL2-BDNF-TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia. Neuropathol Appl Neurobiol. 2022; 48(4):e12799. DOI: 10.1111/nan.12799. View

16.

Hadjihambi A, Konstantinou C, Klohs J, Monsorno K, Le Guennec A, Donnelly C . Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction. J Hepatol. 2022; 78(1):180-190. DOI: 10.1016/j.jhep.2022.08.008. View

17.

Gorg B, Morwinsky A, Keitel V, Qvartskhava N, Schror K, Haussinger D . Ammonia triggers exocytotic release of L-glutamate from cultured rat astrocytes. Glia. 2009; 58(6):691-705. DOI: 10.1002/glia.20955. View

18.

Azhari H, Swain M . Role of Peripheral Inflammation in Hepatic Encephalopathy. J Clin Exp Hepatol. 2018; 8(3):281-285. PMC: 6175767. DOI: 10.1016/j.jceh.2018.06.008. View

19.

Oenarto J, Karababa A, Castoldi M, Bidmon H, Gorg B, Haussinger D . Ammonia-induced miRNA expression changes in cultured rat astrocytes. Sci Rep. 2016; 6:18493. PMC: 4709596. DOI: 10.1038/srep18493. View

20.

Ding S, Wang C, Wang W, Yu H, Chen B, Liu L . Autocrine S100B in astrocytes promotes VEGF-dependent inflammation and oxidative stress and causes impaired neuroprotection. Cell Biol Toxicol. 2021; 39(5):1-25. DOI: 10.1007/s10565-021-09674-1. View